<DOC>
	<DOCNO>NCT02176421</DOCNO>
	<brief_summary>A prospective , open label , study evaluate JUVÉDERM® VOLBELLA lidocaine treatment correction skin depression infra-orbital area ( eye )</brief_summary>
	<brief_title>A Prospective , Open Label Study Evaluating JUVÉDERM® VOLBELLA With Lidocaine Treatment Correction Skin Depressions Infra-orbital Area</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<criteria>Has Grade &gt; 0 screen within eye ( bilateral skin depression infraorbital area ) , evaluate Evaluating Investigator ( EI ) use AIRS Agree refrain undergo antiwrinkle/volumizing treatment upper twothirds face ( eyebrow cheeks/cheekbones ) duration study Has undergone cosmetic facial procedure [ e.g. , facelift , surgery may alter appearance infraorbital area ( laser , photomodulation , intense pulse light , radio frequency , dermabrasion , moderate great depth chemical peel , ablative procedure ) , tissue augmentation dermal filler fat injection , mesotherapy ] anywhere face , Vistabel® cosmetic injection periorbital area , within 6 month prior entry study planning undergo procedure time study . NOTE : Prior treatment HA filler and/or collagen allow , provide treatment administer 12 month prior study entry Has undergone volumizing mid face within 12 month prior study entry Has ever receive semipermanent filler permanent facial implant ( e.g. , calcium hydroxylapatite , polyLlactic acid , polymethylmethacrylate , silicone , expand polytetrafluoroethylene ) anywhere infraorbital area , plan implant product time study Have history skin cancer Have history hypertrophic scar Have subcutaneous retaining structure face ( e.g. , meshing , gold strand )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>